Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg).

Lister RK, Jolles S, Whittaker S, Black C, Forgacs I, Cramp M, Potter M, Rustin MH.

DOI: 10.1067/mjd.2000.104001
Published: 2000-08-01
Container: J Am Acad Dermatol
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1067/mjd.2000.104001,
  title = {Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg).},
  author = {Lister RK and  Jolles S and  Whittaker S and  Black C and  Forgacs I and  Cramp M and  Potter M and  Rustin MH.},
  year = {2000},
  journal = {J Am Acad Dermatol},
  doi = {10.1067/mjd.2000.104001},
  url = {https://doi.org/10.1067/mjd.2000.104001}
}

RIS

TY  - JOUR
TI  - Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg).
AU  - Lister RK
AU  -  Jolles S
AU  -  Whittaker S
AU  -  Black C
AU  -  Forgacs I
AU  -  Cramp M
AU  -  Potter M
AU  -  Rustin MH.
PY  - 2000
JO  - J Am Acad Dermatol
DO  - 10.1067/mjd.2000.104001
UR  - https://doi.org/10.1067/mjd.2000.104001
ER  -

APA

RK, L., S, J., S, W., C, B., I, F., M, C., M, P., & MH., R. (2000). Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg).. J Am Acad Dermatol. https://doi.org/10.1067/mjd.2000.104001

Source records

europe-pmc · retrieved 2026-09-25T20:37:45.227Z